Most babies born with otoferlin deafness get cochlear implants in infancy and they are hence ineligible for that trial. The implants somewhat alter the cochlea, which could hamper the interpretation of gene therapy results. The mutated otoferlin gene destroys a protein while in the interior ear’s hair cells necessary https://artsuppliesonline.us/products/white-cream-face-body-paint-for-halloween-cosplay-mime